Abstract
Tuberculosis (TB) is the highest-mortality infectious disease in the world and the main cause of death related to antimicrobial resistance, yet its surveillance is still paper-based. Rifampicin-resistant TB (RR-TB) is an urgent public health crisis. The World Health Organization has, since 2010, endorsed a series of rapid diagnostic tests (RDTs) that enable rapid detection of drug-resistant strains and produce large volumes of data. In parallel, most high-burden countries have adopted connectivity solutions that allow linking of diagnostics, real-time capture, and shared repository of these test results. However, these connected diagnostics and readily available test results are not used to their full capacity, as we have yet to capitalize on fully understanding the relationship between test results and specific rpoB mutations to elucidate its potential application to real-time surveillance. We aimed to validate and analyze RDT data in detail, and propose the potential use of connected diagnostics and associated test results for real-time evaluation of RR-TB transmission. We selected 107 RR-TB strains harboring 34 unique rpoB mutations, including 30 within the rifampicin resistance-determining region (RRDR), from the Belgian Co...Continue Reading
References
Jul 1, 2006·Science·Sebastien GagneuxBrendan J M Bohannan
Feb 13, 2009·PLoS Medicine·Andreas SandgrenMegan B Murray
Sep 18, 2009·Journal of Clinical Microbiology·A Van DeunA Wright
Nov 6, 2009·PloS One·Thomas R IoergerJames C Sacchettini
Oct 1, 2011·Future Microbiology·Stephen D Lawn, Mark P Nicol
Apr 27, 2012·Journal of Clinical Microbiology·Soumitesh ChakravortyDavid Alland
May 1, 2012·Bioinformatics·Matthew KearseAlexei Drummond
Jun 14, 2013·Journal of Clinical Microbiology·Leen RigoutsArmand Van Deun
Sep 3, 2013·Nature Genetics·Maha R FarhatMegan Murray
Jan 13, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A Van DeunB C de Jong
Sep 30, 2015·PLoS Medicine·Keira A CohenAshlee M Earl
Nov 26, 2015·The Lancet. Respiratory Medicine·Emily A KendallDavid W Dowdy
Jan 12, 2016·PloS One·Halima M SaidNazir A Ismail
Apr 20, 2016·Antimicrobial Agents and Chemotherapy·S B GeorghiouT C Rodwell
Jul 10, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·E AndreC Boehme
Aug 16, 2016·BMC Infectious Diseases·Irfan UllahArshad Javaid
Oct 19, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G J FoxB J Marais
Sep 25, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E AndreE Cambau
Oct 21, 2016·Microbiology Spectrum·Madhukar PaiCatharina C Boehme
Oct 30, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T M WalkerT E A Peto
Jan 4, 2017·International Journal of Mycobacteriology·Ernest A OchangMartin M Meremikwu
Feb 22, 2017·PLoS Medicine·Helen CoxMark Nicol
Apr 28, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Elmira GurbanovaAlan Altraja
Jun 22, 2017·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Hofmann-ThielK Kranzer
Citations
Feb 14, 2020·Journal of Medical Internet Research·Yejin LeeAntoine Flahault
Oct 28, 2019·Journal of Clinical Microbiology·Brian Weinrick
Sep 17, 2019·PeerJ·Kamela C S NgConor J Meehan
Aug 16, 2019·Scientific Reports·Gabriela TorreaBouke C De Jong